KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Inventory (2018 - 2025)

Twist Bioscience (TWST) has disclosed Inventory for 5 consecutive years, with $39.3 million as the latest value for Q3 2022.

  • On a quarterly basis, Inventory rose 23.61% to $39.3 million in Q3 2022 year-over-year; TTM through Sep 2022 was $39.3 million, a 23.61% increase, with the full-year FY2022 number at $39.3 million, up 23.61% from a year prior.
  • Inventory was $39.3 million for Q3 2022 at Twist Bioscience, down from $43.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $43.0 million in Q2 2022 to a low of $4.4 million in Q1 2019.
  • A 5-year average of $17.3 million and a median of $12.7 million in 2020 define the central range for Inventory.
  • Peak YoY movement for Inventory: rose 21.6% in 2019, then skyrocketed 200.09% in 2021.
  • Twist Bioscience's Inventory stood at $5.6 million in 2018, then soared by 33.36% to $7.4 million in 2019, then skyrocketed by 80.81% to $13.4 million in 2020, then surged by 200.09% to $40.2 million in 2021, then dropped by 2.32% to $39.3 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Inventory are $39.3 million (Q3 2022), $43.0 million (Q2 2022), and $40.2 million (Q4 2021).